Researchers at the Strelitz Diabetes Center are working with the following scientists:
Islet Cell RegenerationDr. Lawrence Rosenberg of McGill University in
Montreal, Canada on the comparison of ilotropin, INGAP15, INGAPP
Dr. Donald Dafoe of Stanford University Medical Center on
neoislet fetal grafts and the application of INGAP with growth factor on islet cell
transplantation
Dr. Juan Jose Gargliardino of the Center for Experimental
Endocrinology at the University of La Plata in Argentina on islet neogenesis in high
sucrose fed hamsters
Dr. Sonya Wolfe-Coote and Dr. Johan Louw of the
Experimental Biology Programme, Capetown on islet cell regeneration in monkeys
Dr. Naomi Levitt and Dr. Philip Kay of the University of
Capetown Medical Center on islet cell neogenesis in alcohol induced pancreatitis and other
human diseases
Dr. Helena Edlund of Umea University in Sweden on gene and
protein expression in the pancreatic development on the mouse
Dr. Camillo Ricordi of the University of Miami on research
of piglet islet clusters
Dr. Gerald Gold and Dr. Anne Miller of Eli Lilly and Co.
on the role of INGAP in islet neogenesis
Dr. J. H. Johnson of Parke-Davis on the role of INGAP in
the pancreas of troglitazone-treated diabetic rats.
Dr. Ramon Gomis, Hospital Clinic de Barcelona in Spain on
the effect of tungstate treatment of diabetic rats on INGAP expression.
Dr. Ed Leiter of Jackson Laboratory, Maine on the effects
of genetic manipulation on the expression of INGAP.
Dr. David Harlan at the NIH in Bethesda, Maryland looking
at transgenic models for INGAP over-expression and knockout.
Dr. Timo Otonkoski at the University of Helsinki in
Finland to examine the effects of INGAP on pancreatic islet development in vitro.
Dr. Guy Rousseau and Dr. Patrick Jacquemin at the
Universite Catholique de Louvain in Brussels to examine the expression of INGAP during
pancreatic development in the fetus.
|
